Drug factory · FDA FEI 3010164760
Eurofins Pharma Quality Control
9 avenue de Laponie ZAI de Courtaboeuf, Les Ulis, France
Problems found, fixed voluntarily at FDA's last inspection, Mar 17, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2017: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Zonisamide | Tests it | Advanz Pharma (US) Corp. | 59212-680, 59212-681 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 17, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 8, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis.